𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia

✍ Scribed by Jiazhuo Liu; Yingchang Mi; Mingwei Fu; Wenjuan Yu; Ying Wang; Dong Lin; Shougeng Bian; Jianxiang Wang

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
203 KB
Volume
84
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A scoring system to predict the risk of
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia
✍ David ValcΓ‘rcel; Pau Montesinos; Isabel SΓ‘nchez-Ortega; Salut Brunet; Jordi Este πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 196 KB

## Abstract ## BACKGROUND: A prognostic index to predict induction death in adult patients receiving induction chemotherapy for de novo acute myeloid leukemia (AML) was developed. ## METHODS: The authors analyzed 570 patients (aged 16‐70 years) included in 2 multicenter trials of the CETLAM Grou

Comparison of allogeneic stem cell trans
Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia
✍ Apostolia-Maria Tsimberidou; Niki Stavroyianni; Nora Viniou; Maria Papaioannou; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 148 KB

## Abstract ## BACKGROUND Postremission therapy is critical in maintaining complete remission (CR) in patients with de novo acute myelogenous leukemia (AML). The aim of this trial was to compare allogeneic stem cell transplantation (SCT), high‐dose cytarabine (ara‐C; HiDAC), and autologous SCT as